Introduction
============

Desert hedgehog (DHH), the testis-specific member of mammalian hedgehog (Hh) protein family, is one of the first genes to be expressed in the developing male gonad ([@bib2]). Blocking Hh signalling in the developing testis genetically or pharmacologically leads to severe disruption in testicular histology resulting in spermatogenic defects and infertility ([@bib5], [@bib25], [@bib37]). In addition to the disorganised seminiferous epithelium, disrupted spermatogenesis may partly be due to low androgen levels since Hh signalling is needed for the differentiation of foetal Leydig cells ([@bib38], [@bib1]) and to maintain the expression of steroidogenic enzymes ([@bib3]). Regulation of the Hh pathway in the testis is poorly understood but recent data suggest that environmental factors can interfere with it. [@bib8] reported that maternal smoking during pregnancy impinges on *DHH* mRNA levels during testis development *in utero*. Our previous results demonstrate that the antiandrogen flutamide down-regulates the mRNA levels of Hh pathway genes ([@bib3]).

The role of Hh signalling in spermatogenesis has remained unknown until recently. In the mouse, Sertoli cell-derived DHH binds patched (PTCH) receptor on the surface of primary spermatocytes relieving smoothened (SMO) repression and activating glioma-associated oncogene homologue (GLI) transcription factors ([@bib2], [@bib4], [@bib30]). *Gli1* and *Ptch1* are among the first genes whose transcription is triggered in response to the activation of Hh signalling pathway ([@bib11], [@bib16]). In a recent study, [@bib21] confirmed and redefined these findings in another rodent model, the rat, by showing that DHH is produced in Sertoli cells, whereas meiotic and post-meiotic cells stained positively for PTCH1 and SMO. Interestingly, they also demonstrated that late primary spermatocytes, secondary spermatocytes, round spermatids and Leydig cells express PTCH1 in the adult mouse testis. This would suggest that DHH/PTCH1 signalling takes part in control of meiotic divisions and adult-type Leydig cell function. However, it is also highly contradictory to what has been shown previously by [@bib4]. They indicated that *Ptch2* is the only Hh receptor that is highly expressed in adult mouse testis. *In situ* hybridisation revealed that *Ptch2* is strongly expressed in seminiferous tubules, whereas only a weak expression of *Ptch1* can be observed in the interstitium. Besides meiosis Hh signalling is probably active also in spermatogonia that express the genes of the pathway ([@bib27]). However, when seminiferous tubule segments were cultured in hanging drops in the presence of Hh signalling inhibitor, cyclopamine, no significant effects on proliferation of spermatogonia or survival of germ cells were recorded ([@bib28]). Interestingly, Hh signalling inhibition was followed by lower mRNA levels of *Scf* and *Kit* (*c-Kit*) suggesting that it might secondarily affect survival of differentiating germ cells ([@bib39], [@bib9], [@bib34], [@bib35], [@bib36]).

The aim of this study was to elucidate the role of Hh signalling in rat spermatogenesis and to compare the results with the previous findings in the mouse. Our data suggest that Hh signalling acts at many levels during spermatogenesis in the rat testis and shows that one of the physiological functions of Hh signalling is to promote germ cell survival. Inhibition of receptor tyrosine kinases (RTKs; such as KIT) in the prepubertal rat down-modulates Hh signalling *in vivo*, whereas the steady-state levels of *Dhh* mRNA are suppressed by FSH in adult *in vitro* demonstrating that testicular Hh signalling is under endocrine and paracrine control.

Results
=======

The transcripts of Hh signalling pathway components are present in the rat testis at all ages
---------------------------------------------------------------------------------------------

We isolated total RNA from testes of 1, 5, 10, 20, 30, 40 and 60--90-day-old rats (four animals per age group) and used it as a template in qRT-PCR to study if the mRNAs of Hh pathway genes are present in the postnatal rat testis. Transcripts of all the genes that we studied (*Dhh*, *Ptch1*, *Ptch2*, *Gli1*, *Gli2*, *Gli3* and suppressor of fused (*Sufu*)) were detected at every time point ([Fig. 1](#fig1){ref-type="fig"}). Three different patterns were observed: *Dhh*, *Ptch1*, *Gli2* and *Gli3* mRNA levels increased after birth and showed the highest values prepubertally and steadily decreased thereafter ([Fig. 1](#fig1){ref-type="fig"}A and B); the steady-state level of *Gli1* transcript started to decline steadily after birth ([Fig. 1](#fig1){ref-type="fig"}B); *Sufu* mRNA was present at a very low level in young rat testis but its steady-state level increased markedly after puberty ([Fig. 1](#fig1){ref-type="fig"}B). The level of *Ptch2* transcript did not change significantly over time ([Fig. 1](#fig1){ref-type="fig"}A). Statistical significances were tested using one-way ANOVA and are reported against the data point of the highest value in [Fig. 1](#fig1){ref-type="fig"}. To normalise the *Dhh* transcript level to Sertoli cell number, relative mRNA level of FSH receptor (*Fshr*) was studied. *Fshr* is expressed exclusively by Sertoli cells in the rat testis ([@bib10]). *Dhh* level stayed quite constant in the Sertoli cells as the rat grew older, the only significant difference being between postnatal days 5 and 30 ([Fig. 1](#fig1){ref-type="fig"}C). Sonic hedgehog and Indian hedgehog transcripts were not present in the rat testis (data not shown).

Immunohistochemical staining of Hh pathway proteins in mature rat testis
------------------------------------------------------------------------

In accordance with mRNA level findings, the negative regulator of the pathway, SUFU, was located only in early condensing spermatids in the rat testis ([Fig. 2](#fig2){ref-type="fig"}A and B). Developmentally we could first locate SUFU in spermatids of 40-day-old rats ([Fig. 2](#fig2){ref-type="fig"}A). In adult, SUFU protein expression was first observed in step 9 (stage IX) condensing spermatids. The signal was strongest in steps 10--13 (stages X--XIII) spermatids and became weaker towards stage I ([Fig. 2](#fig2){ref-type="fig"}B). SUFU was no longer expressed in steps 15--18 (stages I--VI) condensing spermatids. Interestingly, as shown in [Fig. 2](#fig2){ref-type="fig"}C and D (which are two consecutive sections), the expression of GLI1 in elongating spermatids was quite the opposite: cytoplasm of steps 16--18 (stages II--VI) spermatids stained strongly for GLI1, whereas no signal for GLI1 was observed in steps 9--14 (stages IX--XIV) spermatids. These data suggest that Hh signalling is involved in spermiogenesis, too. In steps 9--14 spermatids (stages IX--XIV) Hh signalling is turned off by SUFU that sequesters GLI1 in the cytoplasm ([@bib12]). Disappearance of SUFU in steps 15--18 (stages I--VI) spermatids allows GLI1 to be reactivated in the late steps of spermiogenesis.

GLI1 expression was observed at three different levels: spermatogonia, spermatocytes and late elongating spermatids ([Fig. 2](#fig2){ref-type="fig"}D and E). Spermatogonial expression of GLI1 was observed quite uniformly in all stages, whereas the staining intensity of GLI1 in stages II--VI pachytene spermatocytes was stronger than in other stages. Primary spermatocytes also expressed PTCH1 ([Fig. 2](#fig2){ref-type="fig"}F). Zygotene spermatocytes weakly expressed the protein and immunopositivity increased towards stage VIII pachytene spermatocytes whereafter PTCH1 was no longer detectable. The meiotic and post-meiotic cell type-specific expression pattern of SUFU, GLI1 and PTCH1 proteins is summarised in [Fig. 3](#fig3){ref-type="fig"}.

Steady-state levels of Hh signalling pathway mRNAs are spermatogenic stage-dependent
------------------------------------------------------------------------------------

Rat spermatogenesis is divided into 14 defined stages, I--XIV ([@bib15]). We used transillumination-assisted microdissection method to cut the seminiferous tubule of five adult rats to segments representing four pooled stages (II--VI, VII and VIII, IX--XII and XIII--I) of the rat seminiferous epithelial cycle. qRT-PCR analysis showed that the *Dhh* and *Gli1* mRNA levels were at their highest in stages II--VI ([Fig. 4](#fig4){ref-type="fig"}A and B). The steady-state levels of *Ptch1* mRNA were significantly higher in stages II--VIII than in stages IX--I ([Fig. 4](#fig4){ref-type="fig"}C). The mRNA level of *Ptch2* was significantly lower in stages XIII--I compared with stages IX--XII ([Fig. 4](#fig4){ref-type="fig"}D). *Sufu* transcript was present at a very low level in stages II--VI and XIII--I, and markedly more in stages VII--XII ([Fig. 4](#fig4){ref-type="fig"}E). Statistical significances were tested using ANOVA.

GLI1 is developmentally expressed in spermatogonia, meiotic and post-meiotic germ cells
---------------------------------------------------------------------------------------

Hh signalling is most active in prepubertal rat testis according to mRNA transcript levels. Thus, we examined the localisation of GLI1 expression in PFA-fixed testicular tissue sections in 5, 10, 20, 30 and 40-day-old rats ([Fig. 5](#fig5){ref-type="fig"}A and C--F). Nuclear localisation of GLI1 was observed already in spermatogonia of 5-day-old rats ([Fig. 5](#fig5){ref-type="fig"}A) that also expressed PTCH1 ([Fig. 5](#fig5){ref-type="fig"}B). At 10, 20, 30 and 40 days of age ([Fig. 5](#fig5){ref-type="fig"}C--F) GLI1 localised to basal spermatogonia and in the more adluminally situated meiotic germ cells. In addition, cytoplasms of elongating spermatids stained positively for GLI1 in 40-day-old rats ([Fig. 5](#fig5){ref-type="fig"}F). Interestingly, all the cells that we encountered while being in the M phase of the cell cycle were strongly immunopositive for GLI1 (data not shown) suggesting that at least some of the GLI1-expressing cells are mitotically active.

Recombinant human FSH down-regulates the steady-state levels of *Dhh* mRNA *in vitro*
-------------------------------------------------------------------------------------

FSH is a major regulator of germ cell differentiation and spermatogenesis. Therefore, we decided to study whether FSH affects *Dhh* mRNA levels *in vitro*. To analyse whether FSH effect on *Dhh* level is stage-specific and dose-dependent, we cultured segments from three distinct stages with five different concentrations of recombinant human FSH. Three individual experiments were done and within each experiment the same treatment was applied on three parallel samples. We have previously shown that FSH elevates the steady-state levels of *Scf* mRNA ([@bib33]), which served as a positive control. FSH up-regulated *Scf* levels in a dose-dependent manner ([Fig. 6](#fig6){ref-type="fig"}A). The highest *Scf* mRNA levels were detected in stages II--VI, which were also stimulated both at 8 and 30 h.

There were no significant changes in the steady-state levels of *Dhh* mRNA at 8 h after the beginning of FSH exposure. However, at 30 h the *Dhh* levels were down-regulated in all three pooled stages but most remarkably in stages VII and VIII ([Fig. 6](#fig6){ref-type="fig"}B). A similar phenomenon was observed in *Gdnf* levels that were down-modulated specifically in stages II--VI but not in the other stages ([Fig. 6](#fig6){ref-type="fig"}C).

Inhibition of Hh signalling *in vitro* increases apoptotic cell death of germ cells
-----------------------------------------------------------------------------------

After seeing the highest levels of Hh pathway mRNAs in stages II--VI we decided to treat 4 mm long stages II--VI segments with cyclopamine, a specific inhibitor of the Hh pathway, *in vitro* for 8 and 16 h. Four rats were used for this experiment. Squash preparations were made from tubule segments for immunocytochemistry to evaluate the number of cleaved caspase-3-positive apoptotic cells in specimens. Cyclopamine increased the number of apoptotic germ cells in both time points and the difference in the number of cleaved caspase-3-positive cells at 16 h was statistically significant ([Fig. 7](#fig7){ref-type="fig"}).

Imatinib mesylate dramatically represses the mRNA levels of *Dhh*, *Ptch1* and *Gli1* in prepubertal rat testis
---------------------------------------------------------------------------------------------------------------

To pursue further the interplay of SCF/KIT, platelet-derived growth factor (PDGF) and Hh signalling we decided to study whether imatinib mesylate-induced inhibition of tyrosine kinases affects the mRNA levels of Hh pathway components *in vivo*. Imatinib mesylate treatment had a dramatic impact on the steady-state levels of *Dhh* ([Fig. 8](#fig8){ref-type="fig"}A), *Ptch1* and *Gli1* mRNAs ([Fig. 8](#fig8){ref-type="fig"}B). Already 24 h after single treatment with the lower dose (50 mg/kg) the relative transcript level of *Dhh* had decreased significantly. Down-modulation of Hh signalling due to diminished ligand production lead to decreased mRNA levels of Hh target genes *Gli1* and *Ptch1* 72 h after the initial exposure.

Discussion
==========

We have elucidated the role of Hh signalling and its regulation in adult rat testis. We show here that Hh signalling promotes germ cell survival and *Dhh* belongs to a group of genes that are regulated by FSH in Sertoli cells in the rat testis. Imatinib-induced inhibition of RTKs interferes with Hh signalling, and immunohistochemical staining of Hh pathway components suggest that Hh signalling is activated in mitotic, meiotic and late post-meiotic germ cells and suppressed in early post-meiotic cells. Our data about the age-dependent relative abundance of Hh pathway mRNAs and localisation of PTCH1 and GLI1 in meiotic cells strengthen the idea that Hh signalling is needed in meiosis. This kind of conclusion was originally drawn by the findings of [@bib2] and [@bib13]. Homozygous *Dhh* mutation on a 129/Sv inbred background and overexpression of human GLI1 in mouse testis, respectively, leads to a halt in spermatogenesis at pachytene spermatocyte stage. These data suggest that Hh signalling needs to be down-modulated before entry into meiotic divisions. Indeed, we can see a down-regulation of Hh pathway target genes, *Ptch1* and *Gli1*, mRNA levels in stages IX--XIV of the rat seminiferous epithelial cycle just before the meiotic divisions. The prepubertal peak in *Dhh*, *Ptch1*, *Gli2* and *Gli3* mRNA levels co-occurs with the appearance of the first spermatocytes ([@bib6], [@bib18]). The steady decrease in *Gli1* level after birth suggests that Hh signalling is active in the rat testis even before the onset of spermatogenesis and, indeed, it has been shown to drive steroidogenesis in foetal-type Leydig cells ([@bib1], [@bib3]).

SUFU localises exclusively in early elongating spermatids but not in other germ cell types that suggests that canonical Hh signalling is shutdown in these cells. The relative transcript level of *Sufu* stays very low until day 30 and increases sharply thereafter supporting its function as a negative regulator of the Hh pathway in early condensing spermatids. According to our immunofluorescent labelling, GLI1 transcription factor is still present in the cytoplasm of late condensing spermatids. However, the existence of a functional Hh receptor in condensing spermatids is not yet known. Recently, more evidence on non-canonical mechanisms of GLI transcription factor activation has emerged and many signalling pathways have been shown to converge on activation of GLI transcription factors ([@bib26], [@bib14]). Thus, it is possible that GLI1 is activated during late spermiogenesis by Hh-independent mechanism.

The question which Hh receptor mediates activation of the pathway in other germ cell types deserves further attention. As mentioned in the Introduction, there are conflicting data about the role of both PTCH1 and PTCH2 in the testis. Their expression pattern both age- and stage-wise was quite different: *Ptch1* shared the pattern of most other Hh pathway genes, whereas *Ptch2* mRNA levels did not change much in different ages or different stages of the rat seminiferous epithelial cycle. In addition, we observed a relatively high mRNA level of *Ptch1* in mouse seminiferous tubule segments (J-A Mäkelä, V Saario & J Toppari 2011, unpublished observation) which indicates that *Ptch1* transcription is not confined to the interstitium in the mouse testis either ([@bib4]). [@bib21] indicated that PTCH1 is expressed in late meiotic cells and post-meiotic cells of the mouse and rat testis. Our immunohistochemical staining showed that already early primary spermatocytes expressed PTCH1 but the signal from post-meiotic cells was weak and indistinguishable from the background. Taken together, these data suggest that PTCH1 may have a more important role in spermatogenesis than PTCH2.

Introduction of a Hh signalling inhibitor raises the number of cleaved caspase-3-positive germ cells markedly indicating that Hh signalling promotes germ cell survival. Since GLI1 and transcripts of *Ptch2*, *Smo*, *Gli1*, *Gli2* and *Gli3* ([@bib27]) are expressed in spermatogonia and cyclopamine has been shown to impinge on *Gli1* mRNA levels *in vitro* ([@bib28]) these data suggest that Hh signalling is involved in the maintenance of spermatogonial cell population, such as GDNF ([@bib20]). Intriguingly, both *Gdnf* and *Dhh* were down-regulated by FSH *in vitro*. In contrast, FSH elevated the mRNA levels of *Scf*, which is important for germ cell survival ([@bib9], [@bib35], [@bib36]). Intricate interaction between different growth and differentiation factors is needed to secure proper renewal of spermatogonial stem cells and differentiation of an appropriate number of spermatogonia further. Contradictory results have been presented about *Gdnf* regulation in the mouse testis ([@bib29]). Hh signalling can be one of the targets of environmental influence on testicular development as suggested by the effects of maternal smoking on the foetal testis ([@bib8]) and the impact of antiandrogen flutamide on rat foetal testis ([@bib3]). The effect of FSH on Sertoli cells is stimulatory and the number of FSH-induced transcripts is two- to six-fold higher than FSH-suppressed transcripts ([@bib19]). The fact that FSH acts differentially on the steady-state levels of *Dhh* and *Scf* mRNAs which are at their highest in stages II--VI of the rat seminiferous epithelial cycle and seem to share an anti-apoptotic function during spermatogenesis is intriguing. Despite having a seemingly similar effect on germ cells they might regulate different aspects of spermatogenesis and FSH is one of the factors that modulates this process.

We have previously reported that 3-day treatment of prepubertal male rats with imatinib on postnatal days 5--7 delayed the formation of germ-line stem cell pool, induced germ cell apoptosis, reduced proliferation of type A spermatogonia and peritubular myoid cells, and resulted in decreased testis weight due to disruption of longitudinal growth of the seminiferous tubules ([@bib23]). Imatinib mesylate is a specific inhibitor of ABL, KIT, PDGFR and ARG tyrosine kinases ([@bib7], [@bib22]) some of which have been proven to be activated by Sertoli cell-derived growth factors in the testis. In this study, imatinib mesylate strongly down-regulated *Dhh* mRNA levels in prepubertal rat testis. This can be explained by an imatinib mesylate-induced disturbance in the mechanism that normally sustain *Dhh* expression and demonstrates that the paracrine milieu affects the activity of Hh signalling in the rat testis. Imatinib-induced apoptosis might also contribute to the changes in *Dhh*, *Ptch1* and *Gli1* mRNA levels. However, since the incidence of apoptosis was not affected in a uniform way ([@bib23]) after imatinib treatment but *Dhh* levels were, apoptosis cannot explain the changes alone. Interestingly, [@bib28] showed recently that inhibition of Hh signalling impinges on *Scf* and *Kit* mRNA levels in cultured mouse seminiferous tubules. Taken together, these data suggest that the testicular paracrine signalling network works interdependently and might collapse if even individual signalling pathways are disrupted.

In summary, we show here that Hh signalling is active in mitotic, meiotic and late post-meiotic cells of the rat seminiferous epithelium. Hh signalling is inhibited in early condensing spermatids. The steady-state levels of Hh pathway mRNAs are at their highest in stages II--VI of the rat seminiferous epithelial cycle. FSH and inhibition of RTK-dependent paracrine signalling pathways suppress Hh signalling by down-regulating ligand production *in vitro* and *in vivo*. In addition, Hh signalling has a physiological role in spermatogenesis in promoting germ cell survival.

Materials and Methods
=====================

Animals, treatment and sample collection
----------------------------------------

Male Sprague--Dawley rats at the ages of 1, 5, 10, 20, 30, 40 days and 2--4 months were housed at the Animal Centre of Turku University (Turku, Finland) in an environment controlled for light (12 h light:12 h darkness), temperature (21±3 °C) and air humidity (55±15%) with free access to food (CRM diet; Special Diet Services, Witham, Essex, UK) and water. Turku University Committee on the Ethics of Animal Experimentation approved all animal experiments.

Five-day-old rats were treated with imatinib mesylate (STI571, Glivec; 50 or 150 mg/kg; Novartis Pharma AG) dissolved in water and injected (injection volume 150 μl) intracavitally into the stomach as described previously ([@bib23]) either once on fifth day of postnatal life or once every day on postnatal days 5--7. Control animals were injected in the same manner with water alone. The rats were killed by cervical dislocation under CO~2~ anaesthesia at 24 (*n*=4), 48 (*n*=4) or 72 (*n*=4) h after treatment or at specific ages mentioned above.

Transillumination-assisted microdissection and culture of seminiferous tubules
------------------------------------------------------------------------------

The testes were decapsulated on a Petri dish containing DMEM/Ham\'s Nutrient Mixture F-12 (1:1 DMEM/F12; Gibco BRL) supplemented with 0.1% (w/v) BSA, penicillin--streptomycin (50 U and 50 μg/ml, respectively; Gibco 15140) and gentamicin sulphate (50 mg/ml; Biowhittaker; Lonza, Walkersville, MD, USA). Using transillumination-assisted microdissection method ([@bib24], [@bib31]) 3--5 mm long segments of pooled stages II--VI, VII and VIII, IX--XII and XIII--I were dissected from five rats and used to study the stage-specific expression of Hh pathway genes. To study the endocrine regulation of gene expression *in vitro* six 2 mm long segments of stages II--VI, VII and VIII and IX--I from three rats were cultured in 1 ml DMEM/F12 medium supplemented with 0.1% (w/v) BSA, penicillin--streptomycin (50 U and 50 μg/ml, respectively; Gibco 15140), gentamicin sulphate (50 mg/ml; Biowhittaker; Lonza) and 1-methyl 3-isobutyl xanthine (0.2 mmol/l; Aldrich Chemie, Steinheim, Germany) in the presence of recombinant human FSH (Gonal F, Serono). Doses of 1, 10, 25, 50 and 200 ng/ml of rhFSH were used to study responsiveness of *Dhh*, *Scf* and *Gdnf* mRNA expression. Within individual experiments each dose was applied on three parallel samples. After 8 and 30 h incubation (34 °C, 5% CO~2~, humidified atmosphere) the cultured segments of rat seminiferous tubules were collected and snap-frozen in liquid nitrogen.

RNA isolation and cDNA synthesis
--------------------------------

Total RNA from freshly collected or cultured segments of rat seminiferous tubules was isolated using Trisure reagent (Bioline, London, UK) according to the manufacturer\'s instructions. Testicular tissue samples were homogenised with a disperser (UltraTurrax; IKA Werke GmbH & Co. KG, Staufen, Germany) in 600 μl RLT buffer (from the Qiagen RNeasy Mini Kit; Qiagen) supplemented with 6 μl β-mercaptoethanol. Thereafter, total RNA was extracted using Qiagen RNeasy Mini Kit according to the manufacturer\'s instructions. After isolation, RNA concentration was measured using NanoDrop device (ND-1000; NanoDrop Technologies, Wilmington, DE, USA). RNA quality was assessed visually by confirmation of intact 28S and 18S ribosomal bands following agarose gel electrophoresis and ethidium bromide staining. Before cDNA synthesis traces of contaminating genomic DNA were removed by treating samples with DNase I (Invitrogen). cDNA was synthesised using DyNAmo SYBR Green 2-step qRT-PCR Kit (Finnzymes, Espoo, Finland); 500 ng of template RNA was reverse transcribed in a 20 μl reaction with oligo(dT) primers. DNase I-treated samples were split to two and one half was used for cDNA synthesis while the other served as a template in RT reaction.

Real-time PCR
-------------

Primer pairs were designed to be located to different exonic sequences using freely online available Primer 3 software (<http://frodo.wi.mit.edu/>) and gene sequences available at NCBI and Ensembl databases ([Table 1](#tbl1){ref-type="table"}). PCR amplification was performed by MJ Research Chromo4 thermocycler (Bio-Rad Laboratories, Inc.) and the DyNAmo SYBR Green 2-step qRT-PCR Kit (Finnzymes) according to the manufacturer\'s instructions. PCRs for detection of the endogenous control genes, glyceraldehyde-3-phosphate dehydrogenase (*Gapdh*), hypoxanthine phosphoribosyltransferase 1 (*Hprt1*) and S26 ribosomal protein (*S26*), were run for each cDNA template. Quantitative real-time PCR was performed under the following conditions: 95 °C for 15 min followed by 40 cycles of 94 °C for 10 s, 54--64 °C (depending on the primer pair; see [Table 1](#tbl1){ref-type="table"}) for 30 s, and 72 °C for 30 s. Melting curve analysis was carried out immediately following amplification by increasing the temperature in 0.5 °C increments starting at 72 °C for 45 cycles of 1 s each. The specificity of PCR was verified both by the presence of a single melting temperature and by detection of a single band of the expected size on agarose gel. Relative gene expression data was quantified using the 2^−ΔΔ*C*~T~^ method ([@bib17]).

Squash preparations
-------------------

Segments (4 mm long) of stages II--VI of the rat seminiferous epithelial cycle from four rats were incubated 8 and 16 h in the medium and conditions mentioned above in the presence of 100 μmol/l cyclopamine (LC Laboratories, Woburn, MA, USA) or vehicle only. After the incubation the segments were transferred to a Petri dish and cut to 2 mm of length under a stereomicroscope by taking ∼1 mm off from both ends. Squash preparations were made as described by [@bib32]. Briefly, the segments were taken in 15 μl PBS (pH 7.4) onto a microscope slide. The tubule segments were carefully squashed between microscope slides and cover slips and the formation of a cellular monolayer was monitored by phase contrast microscopy. Then the squash preparations were snap-frozen in liquid nitrogen and the cover slips were removed. The slides were incubated in ice-cold 96% (v/v) ethanol for 3 min and allowed to air-dry overnight.

Immunohistochemical staining of Hh pathway components
-----------------------------------------------------

Rat testes were fixed in 4% (v/v) paraformaldehyde at +4 °C overnight. The fixed samples were dehydrated by using graded ethanol solutions and stored in 70% (v/v) ethanol at +4 °C. After paraffin embedding 5 μm thick sections were cut and mounted onto poly-lysine-coated slides. Following rehydration the slides were washed once in PBS and twice in PBS+0.2% (v/v) Triton X-100 for 5 min each. Antigen retrieval was performed by microwaving (300 W) the slides for 15 min in sodium citrate buffer (10 mmol/l, pH 6.0). After washing for 5 min in PBS+0.2% (v/v) Triton X-100 two times, autofluorescence was quenched by treating the slides with 100 mM NHCl~4~ for 3 min. Following washes twice with PBS+0.2% (v/v) Triton X-100 and once with PBS, blocking solution (20% (v/v) normal goat serum or 20% (v/v) BSA in PBS+0.2% (v/v) Triton X-100 for sections that are later incubated with goat or donkey secondary antibodies, respectively) was applied to each section and incubated 1 h at RT. After blocking, sections were incubated overnight at +4 °C in the presence of an aliquot of 100 μl primary antibody (diluted 1:50 in PBS+0.2% (v/v) Triton X-100+1.5% (v/v) NGS or BSA; see above). Primary antibodies used were: goat polyclonal anti-PTCH1 (sc-6149; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), rabbit polyclonal anti-GLI1 (sc-20687, Santa Cruz Biotechnology, Inc.) and goat polyclonal anti-SUFU (sc-10933, Santa Cruz Biotechnology, Inc.). Primary antibody incubation was omitted in negative controls.

Secondary antibodies used were Texas Red-conjugated donkey anti-goat (sc-2783, Santa Cruz Biotechnology, Inc.) and Alexa Fluor 594-conjugated anti-rabbit antibody (A11037, Invitrogen). After 1 h secondary antibody incubation the slides were washed three times with PBS and mounted with UltraCruz mounting medium (sc-24941, Santa Cruz Biotechnology, Inc.). Images were captured using a Leica DFC320 camera (Leica, Wetzlar, Germany) installed on a DMRBE microscope from the same manufacturer. Four histological sections from at least three different animals were included in all IHC analyses.

Immunocytochemical staining of cleaved caspase-3 on the squash preparations
---------------------------------------------------------------------------

Air-dried squash preparations were stored at −80 °C and fixed in 4% (v/v) paraformaldehyde for 10 min. After fixation they were washed twice with Tris-buffered saline (TBS, pH 7.55) for 5 min and antibody penetration was improved by incubating the slides 10 min in TBS+0.2% (v/v) Triton X-100. From this step on cleaved caspase-3 staining was performed by Novocastra Novolink Polymer Detection Systems (Leica Microsystems, Inc., Bannockburn, IL, USA) according to the manufacturer\'s instructions. Cleaved caspase-3 primary antibody was purchased from Cell Signalling Technology (Asp175, Beverly, MA, USA) and used at a dilution of 1:200.

Statistical analysis
--------------------

The results were analysed for statistically significant differences using ANOVA, followed by Tukey\'s test for multiple comparisons of independent groups of samples. Student\'s *t*-test was used for pairwise comparison. The *P* values \<0.05 were considered statistically significant.
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![Age-dependent steady-state levels of Hedgehog pathway mRNAs in the rat testis. (A and B) *Dhh*, *Ptch1*, *Gli2* and *Gli3* mRNAs are at their highest level in prepubertal rat testis. *Gli1* levels steadily decrease after birth. Until day 30 *Sufu* transcript is present at a very low level. *Ptch2* mRNA level does not change within this time window. (C) *Dhh* levels show only slight changes when normalised to Sertoli cell number (*Fshr* mRNA level). Statistical significances were tested using ANOVA and they are marked here against the data point of the highest value. GOI, gene of interest; *n*=4, [s.e.m.]{.smallcaps}; ^a^*P*\<0.05; ^b^*P*\<0.01; ^c^*P*\<0.001; letters a, b and c on top of the error bars are in different colours based on the colour of the line marking the gene.](REPRO110110f01){#fig1}

![Expression of SUFU, GLI1 and PTCH1 in mature rat testis. (A) SUFU expression (red) is first observed in 40-day-old rat in elongating spermatids. (B) In the adult rat testis, the expression starts in step 9 spermatids (stage IX) and stays at a high level till steps 12--13 spermatids (stages XII and XIII). Protein expression is down-regulated thereafter and steps 15--19 spermatids cease to express SUFU (red). (C and D) Two consecutive sections showing that the expression of SUFU (red) (C) and GLI1 (red) (D) are opposite in elongating spermatids, i.e. SUFU is expressed in steps 9--13 spermatids, whereas GLI1 is expressed in steps 16--18 spermatids. (D and E) GLI1 (red) displays a nuclear expression in spermatogonia (arrows) and nuclear/cytoplasmic expression in spermatocytes (arrowheads) while the cytoplasm of steps 16--18 spermatids stains positively for GLI1 (red). Note that stages II--VI pachytene spermatocytes stain more strongly than other primary spermatocytes. (F) Primary spermatocytes stain positively for PTCH1 (red). Pachytene spermatocytes (arrowheads) strongly express the protein whereas a weaker signal is detected in zygotene spermatocytes (arrows). Inset: negative control showing unspecific staining in the interstitium. Cell nuclei are stained in A with DAPI (blue). In B--F DAPI staining (blue) for the same section (sectors) is included to help seminiferous epithelial cycle stage recognition. The stages of the cycle of the seminiferous epithelium are indicated with Roman numerals. Scale bar 100 μm.](REPRO110110f02){#fig2}

![Schematic illustration of the SUFU, GLI1 and PTCH1 protein expression in the meiotic and post-meiotic cells of the rat seminiferous epithelial cycle. GLI1 expression is first observed in preleptotene spermatocytes and the strongest immunostaining is observed in stages II--VI pachytene spermatocytes. Thereafter, the expression is down-regulated but it reappears in steps 15--18 spermatids. PTCH1 expression ranges from zygotene to stage VIII pachytene spermatocytes. SUFU localises specifically to steps 9--14 spermatids. Solid lines mark the cell types with the strongest signal in immunohistochemical staining, whereas the dotted lines show the cell types where the protein is expressed at a lower level. The specific cell associations in the vertical columns represent specific stages (Roman numerals) of the rat seminiferous epithelial cycle. Arabic numerals refer to different steps of post-meiotic germ cell differentiation. In, intermediate spermatogonia; B, type B spermatogonia; Pl, preleptotene spermatocytes; L, leptotene spermatocytes; Z, zygotene spermatocytes; P, pachytene spermatocytes; Di, diplotene spermatocytes; m2°m, meiotic divisions.](REPRO110110f03){#fig3}

![Steady-state levels of Hedgehog pathway mRNAs in rat seminiferous epithelial cycle. (A) *Dhh* and (B) *Gli1* levels are high in stages II--VI compared with other stages. (C) The lowest mRNA level for *Ptch1* and (D) *Ptch2* is recorded in stages XIII--I. (E) Transcript levels of *Sufu* are high in stages VII--XII. *n*=5, [s.e.m.]{.smallcaps}; \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001 compared with stages of the highest value. ^§^*P*\<0.05; ^§§^*P*\<0.01 compared with stages of the second highest value.](REPRO110110f04){#fig4}

![Developmental expression of GLI1 (red) in rat spermatogonia, spermatocytes and elongating spermatids. (A) Spermatogonia (arrows) of 5-day-old rats are immunopositive for GLI1 (red) and for (B) PTCH1 (red; arrows). Spermatogonia (arrows) and spermatocytes (arrowheads) of (C) 10, (D) 20, (E) 30 and (F) 40-day-old rats stain positively for GLI1 (red). (F) Adluminally located elongating spermatids of 40-day-old rats also express GLI1 (red). Inset: negative control. Cell nuclei are stained with DAPI (blue). Insets with smaller magnification represent the same tissue sections with DAPI staining (blue). Scale bar: (A and B) 25 μm, (C--F) 50 μm.](REPRO110110f05){#fig5}

![FSH effect on the steady-state levels of *Scf*, *Dhh* and *Gdnf* mRNAs in rat seminiferous tubules *in vitro*. (A) FSH up-regulates the mRNA level of *Scf* in all stages already 8 h after the treatment. (B) *Dhh* mRNA level is down-regulated in all stages at 30 h after the FSH treatment. (C) *Gdnf* mRNA levels decline significantly specifically in stages II--VI of the rat seminiferous epithelial cycle in response to FSH treatment. *n*=3, [s.e.m.]{.smallcaps}; \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001.](REPRO110110f06){#fig6}

![Effect of Hedgehog signalling inhibition on occurrence of apoptosis in rat seminiferous tubules *in vitro*. Cyclopamine-induced inhibition of Hedgehog signalling *in vitro* leads to an increase in the number of cleaved caspase-3-positive cells 8 and 16 h after the treatment. *n*=3--4, [s.e.m.]{.smallcaps}; \**P*\<0.05.](REPRO110110f07){#fig7}

![Imatinib mesylate-induced inhibition of tyrosine kinases impinges on Hedgehog signalling in prepubertal rat testis *in vivo*. (A) Imatinib treatment leads to down-regulated level of *Dhh* mRNA. (B) In response to reduced ligand production, a drop in *Gli1* and *Ptch1* mRNA levels is observed 72 h after the initial exposure. GOI, gene of interest; PND, postnatal day; *n*=4, [s.e.m.]{.smallcaps}; \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001.](REPRO110110f08){#fig8}

###### 

Primer design, annealing temperatures and PCR product lengths of the studied rat mRNAs.

  **Gene**   **Accession number**                                                 **Annealing temperature** (°C)   **Primers**                  **Product length** (bp)
  ---------- -------------------------------------------------------------------- -------------------------------- ---------------------------- -------------------------
  *Dhh*      [AF148226](http://www.ncbi.nlm.nih.gov/gene?term=AF148226)           64                               5′-GACCTCGTCCCCAACTACAA-3′   159
                                                                                                                   5′-AACCTTCAGTCACGCGTAGG-3′   
  *Ptch1*    [NM_053566](http://www.ncbi.nlm.nih.gov/gene?term=NM_053566)         58                               5′-GGCTGAGAGCGAAGTTTCAA-3′   271
                                                                                                                   5′-GCCTCTGTGGTCAGGACATT-3′   
  *Ptch2*    [NM_01108975](http://www.ncbi.nlm.nih.gov/gene?term=NM_01108975)     63                               5′-CCAGGAACCTCTGGATTTCA-3′   207
                                                                                                                   5′-GATGCGAAGGTTCTCTCCAG-3′   
  *Gli1*     [XM_345832](http://www.ncbi.nlm.nih.gov/gene?term=XM_345832)         63                               5′-GGTTATGGGTCTGCCAGAGA-3′   159
                                                                                                                   5′-GCTGGGTGAGGTACGGATTA-3′   
  *Gli2*     [NM_001107169](http://www.ncbi.nlm.nih.gov/gene?term=NM_001107169)   60                               5′-TACGAGACCAACTGCCACTG-3′   235
                                                                                                                   5′-CCTTTGAGCAGCCTTCAAAC-3′   
  *Gli3*     [XM_225411](http://www.ncbi.nlm.nih.gov/gene?term=XM_225411)         59                               5′-TTCTGAACCCTGTCCAGGTC-3′   207
                                                                                                                   5′-TCTTTGTCCCCTTCCTCCTT-3′   
  *Sufu*     [NM_001024899](http://www.ncbi.nlm.nih.gov/gene?term=NM_001024899)   60                               5′-GGTCCCTGGCTGATAACTGA-3′   224
                                                                                                                   5′-GTCTTTGCCAGACAGCCTTC-3′   
  *Ihh*      [NM_053384](http://www.ncbi.nlm.nih.gov/gene?term=NM_053384)         60                               5′-GACCGCGACCGAAATAAGTA-3′   182
                                                                                                                   5′-ACGCTCCCCAGTTTCTAGGT-3′   
  *Shh*      [NM_017221](http://www.ncbi.nlm.nih.gov/gene?term=NM_017221)         60                               5′-GGAACTCACCCCCAATTACA-3′   151
                                                                                                                   5′-TCACTCGAAGCTTCACTCCA-3′   
  *Fshr*     [NM_199237](http://www.ncbi.nlm.nih.gov/gene?term=NM_199237)         56                               5′-CCTCTGGGCCAGTCATTTTA-3′   213
                                                                                                                   5′-GTTCAGAGATTTGCCGCTTC-3′   
  *Scf*      [NM_021843](http://www.ncbi.nlm.nih.gov/gene?term=NM_021843)         61                               5′-CAAAACTGGTGGCGAATCTT-3′   218
             [NM_021844](http://www.ncbi.nlm.nih.gov/gene?term=NM_021844)                                          5′-GCCACGAGGTCATCCACTAT-3′   
  *Gdnf*     [NM_019139](http://www.ncbi.nlm.nih.gov/gene?term=NM_019139)         61                               5′-CGGACGGGACTCTAAGATGA-3′   205
                                                                                                                   5′-CGTCATCAAACTGGTCAGGA-3′   
  *Gapdh*    [NM_017008](http://www.ncbi.nlm.nih.gov/gene?term=NM_017008)         55                               5′-AGACAGCCGCATCTTCTTGT-3′   207
                                                                                                                   5′-CTTGCCGTGGGTAGAGTCAT-3′   
  *Hprt1*    [NM_012583](http://www.ncbi.nlm.nih.gov/gene?term=NM_012583)         54                               5′-AAGCTTGCTGGTGAAAAGGA-3′   185
                                                                                                                   5′-CCGCTGTCTTTTAGGCTTTG-3′   
  *S26*      [XM_001066146](http://www.ncbi.nlm.nih.gov/gene?term=XM_001066146)   57                               5′-AAGGAGAAACAACGGTCGTG-3′   300
                                                                                                                   5′-GCAGGTCTGAATCGTGGTG-3′    

*Dhh*, desert hedgehog; *Ptch*, patched; *Gli1*, glioma-associated oncogene homologue; *Sufu*, suppressor of fused; *Ihh*, Indian hedgehog; *Shh*, sonic hedgehog; *Fshr*, FSH receptor; *Gdnf*, glial cell line-derived neurotrophic factor; *Scf*, stem cell factor; *Gapdh*, glyceraldehyde-3-phosphate dehydrogenase; *Hprt1*, hypoxanthine phosphoribosyltransferase 1; *S26*, S26 ribosomal protein.
